Serial Number
98573399
Owner
Scripta Insights, Inc.Attorney
Jacqueline ZionFirst Use Date
Dec 5, 2025
Filing Date
May 29, 2024
THE RX NAVIGATION COMPANY Trademark
Serial Number: 98573399
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Jacqueline Zion Pearl Cohen LLP
7 Times Square, 19th Fl
New York, NY 10036
United States
Trademark Details
Filing Date
May 29, 2024
Registration Date
Not Registered
First Use Anywhere
December 5, 2025
First Use in Commerce
December 5, 2025
Published for Opposition
March 4, 2025
Goods & Services
Cloud-based software as a service, namely, providing online non-downloadable computer software for pharmaceutical cost management services and drug utilization review based on the gathered information, for providing recommendations to the health care providers and employers regarding prescription drug costs, co-payments for prescriptions, and comparable and cost-effective alternative drugs to those prescribed
(Based on Use in Commerce) Pharmaceutical cost management services and drug utilization review services based on the gathered information, for providing recommendations to the health care providers and employers regarding prescription drug costs, co-payments for prescriptions, and comparable and cost-effective alternative drugs to those prescribed
Computer software, namely, downloadable software and downloadable mobile application for pharmaceutical cost management and drug utilization review based on the gathered information, for providing recommendations to the health care providers and employers regarding prescription drug costs, co-payments for prescriptions, and comparable and cost-effective alternative drugs to those prescribed
